Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Oct 15, 2026 7:30 am EDT

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Sep 8, 2026 1:55 pm EDT

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

Aug 13, 2026 9:15 am EDT

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests

Jul 27, 2026 4:05 pm EDT

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results

Jul 23, 2026 12:30 pm EDT

OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026

Jun 15, 2026 8:00 am EDT

Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026

May 12, 2026 8:00 am EDT

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

Apr 30, 2026 8:30 am EDT

OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

Apr 30, 2026 8:00 am EDT

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

Apr 28, 2026 4:05 pm EDT

OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results